These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7466636)

  • 41. Diuretic usage in heart failure: a continuing conundrum in 2005.
    Gupta S; Neyses L
    Eur Heart J; 2005 Apr; 26(7):644-9. PubMed ID: 15734765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Furosemide].
    Fillastre JP; Apoil E; Godin N; Temperville B
    Rev Prat; 1978 Nov; 28(51):4035-6, 4039-40, passim. PubMed ID: 741189
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of chronic circulatory insufficiency].
    Sivkov II
    Klin Med (Mosk); 1977 Jun; 55(6):9-16. PubMed ID: 895034
    [No Abstract]   [Full Text] [Related]  

  • 44. [Unconventional treatment of severe heart failure in the elderly].
    Fidelman Z; Korshun Z
    Harefuah; 2000 Mar; 138(5):354-6, 424. PubMed ID: 10883130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drugs used in heart disease. 1. Pharmacology--1.
    Landowski R; Shulman R; Davies R
    Nurs Times; 2002 Apr 30-May 6; 98(18):43-6. PubMed ID: 12035447
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of furosemide on the respiratory gas exchange and the acid-base balance].
    Veltkamp U; Muysers K; Smidt U
    Arzneimittelforschung; 1968 Sep; 18(9):1207-9. PubMed ID: 5755939
    [No Abstract]   [Full Text] [Related]  

  • 47. Subcutaneous furosemide.
    Goenaga MA; Millet M; Sánchez E; Garde C; Carrera JA; Arzellus E
    Ann Pharmacother; 2004 Oct; 38(10):1751. PubMed ID: 15340122
    [No Abstract]   [Full Text] [Related]  

  • 48. [Differential therapy of chronic heart failure].
    Riegger AJ
    Internist (Berl); 1993 Oct; 34(10):939-43. PubMed ID: 8225843
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Furosemide therapy of edematogenic syndromes].
    Proto C
    Minerva Med; 1966 Mar; 57(24):1042-5. PubMed ID: 5930250
    [No Abstract]   [Full Text] [Related]  

  • 51. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators.
    Martin FL; Chen HH; Cataliotti A; Burnett JC
    Rev Cardiovasc Med; 2008; 9(1):39-45. PubMed ID: 18418308
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and circulatory aspects of digitalis in heart failure.
    Storstein L
    Eur Heart J; 1982 Dec; 3 Suppl D():59-64. PubMed ID: 6761128
    [No Abstract]   [Full Text] [Related]  

  • 54. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
    Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
    J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Saluretics in the treatment of cardiac and renal edema].
    Vorburger C; Cottier P
    Munch Med Wochenschr; 1966 Dec; 108(51):2581-3. PubMed ID: 6013307
    [No Abstract]   [Full Text] [Related]  

  • 56. The investigation and management of patients with heart failure.
    Saunderson EM
    Br J Gen Pract; 1996 Sep; 46(410):551-2. PubMed ID: 8917880
    [No Abstract]   [Full Text] [Related]  

  • 57. [Neurohormonal mechanisms in cardiac insufficiency. Possible therapeutic implications].
    Iannetti MV; Vallebona A; Perocchio M
    Minerva Cardioangiol; 1993 Mar; 41(3):81-9. PubMed ID: 8510813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tolerability and efficacy of high-dose furosemide and small-volume hypertonic saline solution in refractory congestive heart failure.
    Paterna S; Parrinello G; Amato P; Dominguez L; Pinto A; Maniscalchi T; Cardinale A; Licata A; Amato V; Licata G; Di Pasquale P
    Adv Ther; 1999; 16(5):219-28. PubMed ID: 10915397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diuretic treatment for the sodium retention of congestive heart failure.
    Cody RJ; Kubo SH; Pickworth KK
    Arch Intern Med; 1994 Sep; 154(17):1905-14. PubMed ID: 8074594
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pathomechanisms of heart failure].
    Urbaszek W
    Z Arztl Fortbild (Jena); 1993; 87(8 Suppl 4):1-4. PubMed ID: 8105608
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.